Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

3 Résultats
authFullName_s : G. Breysacher

PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

J-B. Bachet , O. Lucidarme , C.B. Levache , E. Maillard , J.L. Raoul et al.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.505P, ⟨10.1093/annonc/mdx393.031⟩
Communication dans un congrès hal-01632415v1

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics

C. Lepage , M. Phelip , L. Cany , E. Maillard , A. Lievre et al.
41st Congress of the European-Society-for-Medical-Oncology (ESMO), Oct 2016, Copenhague, Denmark. pp.483P, ⟨10.1093/annonc/mdw370.31⟩
Communication dans un congrès hal-01507441v1

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

J.B. Bachet , O. Lucidarme , C.B. Levache , E. Barbier , J.L. Raoul et al.
European Journal of Cancer, 2018, 104, pp.108-116. ⟨10.1016/j.ejca.2018.09.006⟩
Article dans une revue hal-01960176v1